Recently, preoperative hematological inflammation and nutrition based indicators, such as albumin (ALB), C-reactive protein (CRP), platelet (PLT) to lymphocyte (LYM) ratio (PLR), neutrophil (NEU) to LYM ratio (NLR), and LYM to monocyte (MON) ratio (LMR), have demonstrated their prognostic roles in various cancers (10–13). The gene discussed is ALB; the disease is cancer.